Effect of some uricosuric and anti-inflammatory drugs on the binding of uric acid to human serum albumin in vitro.
D000493:Allopurinol / Q000494:pharmacology; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology; D001665:Binding Sites; D002210:Caprylates / Q000494:pharmacology; D003078:Colchicine / Q000494:pharmacology; D003956:Dialysis; D005453:Fluorescence; D006801:Humans; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D008528:Mefenamic Acid / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology; D011339:Probenecid / Q000494:pharmacology; D011485:Protein Binding / Q000187:drug effects*; D012709:Serum Albumin; D012980:Sodium Salicylate / Q000494:pharmacology; D013442:Sulfinpyrazone / Q000494:pharmacology; D014527:Uric Acid; D014528:Uricosuric Agents / Q000494:pharmacology*
D000893:Anti-Inflammatory Agents; D002210:Caprylates; D012709:Serum Albumin; D014528:Uricosuric Agents; D014527:Uric Acid; D008528:Mefenamic Acid; D000493:Allopurinol; D010653:Phenylbutazone; D011339:Probenecid; D001241:Aspirin; D003078:Colchicine; D013442:Sulfinpyrazone; D012980:Sodium Salicylate; D007213:Indomethacin